A role for carbapenem in the treatment of melioidosis in developing countries?
Laowansiri
Panthipa
P
Shah
Sundeep
S
Kiratisin
Pattarachai
P
Apisarnthanarak
Anucha
A
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D016957:Burkholderia pseudomallei / Q000187:drug effects*; D015780:Carbapenems / Q000008:administration & dosage / Q000627:therapeutic use; D003646:Debridement; D003906:Developing Countries; D006801:Humans; D007866:Leg / Q000601:surgery; D008297:Male; D008554:Melioidosis / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000077731:Meropenem; D008875:Middle Aged; D013785:Thailand; D013845:Thienamycins / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D013845:Thienamycins; D000077731:Meropenem